mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-05 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0004 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0006 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0006 |
mRNA |
lenalidomide |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0006 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0009 |
mRNA |
BRD-A02303741 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0009 |
mRNA |
Panobinostat |
CCLE |
pan-cancer |
AAC |
-0.13 |
0.002 |
mRNA |
BIX02189 |
GDSC1000 |
pan-cancer |
AAC |
0.098 |
0.002 |